Abstract
Composed of trillions of microorganisms, the human GutM plays a key role in maintaining general health and metabolic homeostasis. MetS is a complex and common health condition characterized by a number of metabolic abnormalities, including obesity, insulin resistance, hypertension, and dyslipidemia. Evidence emerging in recent years indicates that human GutM plays a crucial role in the pathophysiology of MetS. In this chapter, we will discuss the composition and functionality of GutM, as well as the dynamic and complex relationship between GutM's influence on metS development and progression. By reviewing relevant studies and literature, we will try to shed light on potential therapeutic strategies and innovative approaches targeting GutM, mitigating the negative effects of MetS.
Keywords: Microbiota, Metabolic syndrome.